{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:07:03Z","timestamp":1770066423501,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,16]]},"DOI":"10.7759\/cureus.10989","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T17:47:49Z","timestamp":1602870469000},"source":"Crossref","is-referenced-by-count":2,"title":["Patient Outcomes With Dose Escalation Using Modern Radiotherapy Techniques: A Retrospective Review of Anal Cancer Treated at a Large Academic Institution Between 2010 and 2016"],"prefix":"10.7759","author":[{"given":"Sonja C","family":"Murchison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavash","family":"Atrchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups","volume":"15","author":"Bartelink H","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997, 15:2040-2049. 10.1200\/JCO.1997.15.5.2040","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover J","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, et al.. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010, 102:1123-1128. 10.1038\/sj.bjc.6605605","journal-title":"Br J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017, 67:93-99. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref4","article-title":"Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08","volume":"2","author":"John M","year":"1996","unstructured":"John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996, 2:205-211.","journal-title":"Cancer J Sci Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00329-5","article-title":"Time-dose considerations in the treatment of anal cancer","volume":"39","author":"Constantinou EC","year":"1997","unstructured":"Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, Delaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys. 1997, 39:651-657. 10.1016\/S0360-3016(97)00329-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.12.027","article-title":"Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08","volume":"72","author":"Konski A","year":"2008","unstructured":"Konski A, Garcia M Jr, John M, Krieg R, Pinover W, Myerson R, Willett C. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys. 2008, 72:114-118. 10.1016\/j.ijrobp.2007.12.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.1089","article-title":"Personalized dose escalation in anal cancer","volume":"96","author":"Robinson M","year":"2016","unstructured":"Robinson M, Christophides D, Cooper R, et al.. Personalized dose escalation in anal cancer. Int J Radiat Oncol Biol Phys. 2016, 96:e198. 10.1016\/j.ijrobp.2016.06.1089","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1124141","article-title":"Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal","volume":"55","author":"Tomasoa NB","year":"2016","unstructured":"Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal. Acta Oncol. 2016, 55:760-766. 10.3109\/0284186X.2015.1124141","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2015.1028586","article-title":"Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series","volume":"33","author":"Franco P","year":"2015","unstructured":"Franco P, Mistrangelo M, Arcadipane F, et al.. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series. Cancer Invest. 2015, 33:259-266. 10.3109\/07357907.2015.1028586","journal-title":"Cancer Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.03.03","article-title":"Utilization of intensity modulated radiation therapy for anal cancer in the United States","volume":"9","author":"Haque W","year":"2018","unstructured":"Haque W, Verma V, Butler EB, Teh BS. Utilization of intensity modulated radiation therapy for anal cancer in the United States. J Gastrointest Oncol. 2018, 9:466-477. 10.21037\/jgo.2018.03.03","journal-title":"J Gastrointest Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12768","article-title":"Image\u2010guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer","volume":"14","author":"Arcadipane F","year":"2018","unstructured":"Arcadipane F, Franco P, Ceccarelli M, et al.. Image\u2010guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. Asia Pac J Clin Oncol. 2018, 14:217-223. 10.1111\/ajco.12768","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13566-017-0326-3","article-title":"Influence of radiation treatment technique on outcome and toxicity in anal cancer","volume":"6","author":"Fredman ET","year":"2017","unstructured":"Fredman ET, Abdel-Wahab M, Kumar AMS. Influence of radiation treatment technique on outcome and toxicity in anal cancer. J Radiat Oncol. 2017, 6:413-421. 10.1007\/s13566-017-0326-3","journal-title":"J Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2015.08.006","article-title":"Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3 year outcomes at two Sydney institutions","volume":"27","author":"Yates A","year":"2015","unstructured":"Yates A, Carroll S, Kneebone A, et al.. Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3 year outcomes at two Sydney institutions. Clin Oncol (R Coll Radiol). 2015, 27:700-707. 10.1016\/j.clon.2015.08.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic L","year":"2013","unstructured":"Kachnic L, Winter K, Myerson R, et al.. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013, 86:27-33. 10.1016\/j.ijrobp.2012.09.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.11.038","article-title":"Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy","volume":"67","author":"Vuong T","year":"2007","unstructured":"Vuong T, Kopek N, Ducruet T, Portelance L, Faria S, Bahoric B, Devic S. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2007, 67:1394-1400. 10.1016\/j.ijrobp.2006.11.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-2-41","article-title":"Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans","volume":"2","author":"Menkarios C","year":"2007","unstructured":"Menkarios C, Azria D, Lalibert\u00e9 B, et al.. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol. 2007, 2:41. 10.1186\/1748-717X-2-41","journal-title":"Radiat Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00016-6","article-title":"Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study","volume":"56","author":"Vuong T","year":"2003","unstructured":"Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study. Int J Radiat Oncol Biol Phys. 2003, 56:823-831. 10.1016\/S0360-3016(03)00016-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000009","article-title":"Intensity-modulated radiation therapy for anal cancer: results from a multi-institutional retrospective cohort study","volume":"39","author":"Call JA","year":"2016","unstructured":"Call JA, Prendergast BM, Jensen LG, et al.. Intensity-modulated radiation therapy for anal cancer: results from a multi-institutional retrospective cohort study. Am J Clin Oncol. 2016, 39:8-12. 10.1097\/COC.0000000000000009","journal-title":"Am J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2018.0202","article-title":"Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy","volume":"101","author":"Ghareeb A","year":"2019","unstructured":"Ghareeb A, Paramasevon K, Mokool P, van der Voet H, Jha M. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy. Ann R Coll Surg Engl. 2019, 101:168-175. 10.1308\/rcsann.2018.0202","journal-title":"Ann R Coll Surg Engl"},{"key":"ref20","unstructured":"Number and rates of new cases of primary cancer, by cancer type, age group and sex. Table 13-10-0111-01. (2018). Accessed: August 5, 2018: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310011101&pickMembers%5B0%5D=2.1&pickMembers%5B1%5D=3.1&pickMe...."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.12256","article-title":"FDG PET\/CT in the management of colorectal and anal cancers","volume":"203","author":"Agarwal A","year":"2014","unstructured":"Agarwal A, Marcus C, Xiao J, Nene P, Kachnic LA, Subramaniam RM. FDG PET\/CT in the management of colorectal and anal cancers. AJR Am J Roentgenol. 2014, 203:1109-1119. 10.2214\/AJR.13.12256","journal-title":"AJR Am J Roentgenol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.1790","article-title":"Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study","volume":"29","author":"Sunesen KG","year":"2011","unstructured":"Sunesen KG, N\u00f8rgaard M, Lundby L, Havsteen H, Buntzen S, Thorlacius-Ussing O, Laurberg S. Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study. J Clin Oncol. 2011, 29:3535-3540. 10.1200\/JCO.2011.36.1790","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.05.044","article-title":"Intensity modulated radiation therapy versus conventional radiation for anal cancer in the Veterans Affairs system","volume":"102","author":"Bryant AK","year":"2018","unstructured":"Bryant AK, Huynh-Le M, Simpson DR, Mell LK, Gupta S, Murphy JD. Intensity modulated radiation therapy versus conventional radiation for anal cancer in the Veterans Affairs system. Int J Radiat Oncol Biol Phys. 2018, 102:109-115. 10.1016\/j.ijrobp.2018.05.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref24","unstructured":"ISRCTN88455282. PLATO - Personalizing anal cancer radiotherapy dose. (2016). Accessed: August 27, 2019: http:\/\/www.isrctn.com\/ISRCTN88455282."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42405-patient-outcomes-with-dose-escalation-using-modern-radiotherapy-techniques-a-retrospective-review-of-anal-cancer-treated-at-a-large-academic-institution-between-2010-and-2016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:51Z","timestamp":1707506871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42405-patient-outcomes-with-dose-escalation-using-modern-radiotherapy-techniques-a-retrospective-review-of-anal-cancer-treated-at-a-large-academic-institution-between-2010-and-2016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.10989","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,16]]}}}